Beijing-based Anxin Doctor, a mobile app focused on pediatric and women's healthcare, has completed a RMB200 million ($29 million) Series B round of funding across two tranches.
The International Finance Corporation (IFC), the investment arm of the World Bank, has proposed a commitment of $60 million to IDS Medical Systems, a Hong Kong-based healthcare industry supplier for Southeast Asia.
UK-based development finance institution (DFI) CDC Group has partnered with India’s Manipal Education & Medical Group for an $80 million fund targeting healthcare investments in emerging markets.
Judith Li, a partner with Lilly Asia Ventures, discusses healthcare investment opportunities in China
US-based venture capital firm Unitus Impact has led a $6.5 million Series A funding round for Singaporean healthcare technology start-up mClinica.
AGIC Capital is targeting up to three more deals in 2017 as its debut Asia-Europe fund closes at $1 billion, having received strong support from Asian LPs
Chinese private equity firm HG Capital has led a RMB160 million ($23 million) round of funding for Beijing Nuokangda Pharmaceutical Technology, a contract research organization (CRO).
Accel Partners has led a $5.8 million Series A round for Indian healthcare-focused AI start-up SigTuple Technologies.
Indian pharmaceutical company Eris Lifesciences has filed for a domestic IPO that is expected to facilitate a full exit for ChrysCapital Partners, which has been an investor since 2011.
Japan-based investor Beyond Next Ventures has led a JPY380 million ($3.4 million) round for domestic healthcare software developer CureApp.
Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
The investment arm of Singapore's Economic Development Board (EDBI) and B Capital Group have led a $25 million Series B funding round for Singaporean health technology start-up CXA Group.
German healthcare services and equipment provider Fresenius Medical Care has agreed to take control of Australia’s Cura Group, a hospital operator backed by Intermediate Capital Group (ICG).
Qiming Venture Partners has led a $20 million Series A round of funding for Chinese drug developer Connect Biopharmaceuticals.
When EQT Partners acquired Australia-based I-Med Network Radiology, the company had spent years in the hands of different creditors. The GP had to restore confidence internally and drive long-term growth
Private equity and venture capital investment activity in Pakistan remains sparse, but early movers are beginning to cut deals with a new sense of confidence as geopolitical and economic issues simmer down
China's Tencent Holdings has led a $55 million Series D round for Indian clinic management software and doctor search portal developer Practo.
TPG Capital is seeking between $4 billion and $4.5 billion for its seventh pan-Asian fund, having closed the previous vehicle at $3.3 billion in 2014 after a challenging two-year-plus process.
The Abraaj Group has invested an undisclosed sum in Islamabad Diagnostics Centre (IDC), an affordable health diagnostics provider with 20 facilities in Pakistan.
C-Bridge Capital participates in a $100 million Series B round of funding for biotechnology Ascletis alongside existing backer Goldman Sachs and a number of its LPs
Healthcare-focused PE firm C-Bridge Capital has acquired a controlling stake in Anrei Medical Device, a China-based invasive medical devices manufacturer, for $25 million.
Frontier Biotech, a China-based pharmaceutical company that works on HIV treatments, has received RMB300 million ($43 million) in Series C funding, led by Huaxin Century Investment Group.
New Century Healthcare, a Chinese pediatric hospital operator backed by CDH Investments and Boyu Capital, is planning to raise HK$1 billion ($129 million) via a Hong Kong IPO.
Israeli venture capital firm Yozma Group has agreed to invest KRW50 billion ($41.4 million) in Korean biotechnology and healthcare start-ups, starting in the first half of 2017.